Optometry Australia

1 PBAC submission on file, first appeared 2015. 100% have been recommended.

Drug portfolio

Sorted by PBS spend captured. PBS expenditure is credited to the sponsor with the most recent Recommended decision per drug, so biosimilars and originator brands aren't double-counted.

• Betaxolol, bimatoprost, bimatoprost + timolol, brimonidine, brimonidine + timolol, brinzolamide, brinzolamide + timolol, dorzolamide, dorzolamide + timolol, latanoprost, latanoprost + timolol, pilocarpine, timolol, travoprost, timolol + travoprost
  Ophthalmology · Recommended with restriction · 2015—

Therapy area mix

Activity by year

2015 (1)